Myungmun Pharma
KOSPI · Healthcare · ₩41B
₩1,169-1.68%
Price
1195.0원
1163.0원
Jul 27, 26Oct 28, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩51.2B+6.7%
Operating Income-₩836MTurned to loss
Net Income-₩1.7B-63.1%
3/'26 vs prev quarter
Company Health
Market Cap₩41B
Operating Margin+0.8%
Cash on Hand243억원59.3% of market cap
Free Cash Flow-38억원-9.4% of market cap
Short Volume 2.0% · as of 26.10.28
Among 98 제약 peers
LowMedianHigh
PSR0.2xmedian 0.7xPBR0.4xmedian 0.7xROE-2.6%median +5.0%